12:00 AM
 | 
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

bioMerieux, Quanterix deal

bioMerieux received exclusive, worldwide rights to Quanterix's single-molecule array (Simoa) technology for clinical laboratories and industrial applications. Quanterix will develop a new instrument based on the Simoa technology, and bioMerieux will develop...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >